AR240941A2 - Procedimiento para preparar compuestos de pirazolopirimidinas - Google Patents

Procedimiento para preparar compuestos de pirazolopirimidinas

Info

Publication number
AR240941A2
AR240941A2 AR30081585A AR30081585A AR240941A2 AR 240941 A2 AR240941 A2 AR 240941A2 AR 30081585 A AR30081585 A AR 30081585A AR 30081585 A AR30081585 A AR 30081585A AR 240941 A2 AR240941 A2 AR 240941A2
Authority
AR
Argentina
Prior art keywords
alkyl
pyrazolo
pyrimidines
imidazo
production
Prior art date
Application number
AR30081585A
Other languages
English (en)
Other versions
AR240941A1 (es
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of AR240941A2 publication Critical patent/AR240941A2/es
Publication of AR240941A1 publication Critical patent/AR240941A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

UN PROCEDIMIENTO PARA PREPARAR COMPUESTOS DE PIRAZOLOPIRIRDINAS QUE TIENEN LA FORMULA I, DONDE R ES ALQUILO O TRIFLOURALQUILINO, R2 ES ALQUILO Y R3 ES HIDROGENO, ALQUILO O CICLOPROPILO; Y R4 Y R5 HIDROGENO O ALQUILO, PUDIENDO UNO DE R4 Y R5 SER ADEMAS DIALQUILO CUANDO EL OTRO H/H, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, PORQUE COMPRENDE TRATAR UN COMPUESTO QUE TIENE LA FORMULA II CON UN ORTOESTER QUE TIENE LA FORMULA R3 (OR)3 DONDE R1, R2, R3 Y R5 SON TAL COMO SE HAN DEFINIDO ANTERIORMENTE Y R ES ALQUILO
AR300815A 1982-05-24 1985-06-26 Procedimiento para preparar compuestos de pirazolopirimidinas AR240941A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/381,484 US4469868A (en) 1982-05-24 1982-05-24 Alkylimidazo[1,2-c]pyrazolo[3,4-e]pyrimidines

Publications (2)

Publication Number Publication Date
AR240941A2 true AR240941A2 (es) 1991-03-27
AR240941A1 AR240941A1 (es) 1991-03-27

Family

ID=23505215

Family Applications (1)

Application Number Title Priority Date Filing Date
AR300815A AR240941A1 (es) 1982-05-24 1985-06-26 Procedimiento para preparar compuestos de pirazolopirimidinas

Country Status (22)

Country Link
US (1) US4469868A (es)
EP (1) EP0095289B1 (es)
JP (1) JPS58210087A (es)
KR (1) KR870000931B1 (es)
AR (1) AR240941A1 (es)
AT (1) ATE24510T1 (es)
AU (1) AU553708B2 (es)
CA (1) CA1210393A (es)
DE (1) DE3368635D1 (es)
DK (1) DK161968C (es)
ES (4) ES8407051A1 (es)
FI (1) FI74012C (es)
GR (1) GR79262B (es)
HK (1) HK102989A (es)
HU (1) HU187913B (es)
IE (1) IE55111B1 (es)
IL (1) IL68360A (es)
NO (1) NO160444C (es)
NZ (1) NZ204321A (es)
PH (1) PH18454A (es)
PT (1) PT76745B (es)
ZA (1) ZA832637B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000192A1 (en) * 1986-06-26 1988-01-14 Warner-Lambert Company 5-SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDIN-7-ONES
CA2588627A1 (en) * 2004-11-23 2006-07-13 Reddy Us Therapeutics, Inc. Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them
WO2006133261A2 (en) 2005-06-06 2006-12-14 Intra-Cellular Therapies, Inc. Organic compounds
US9006258B2 (en) 2006-12-05 2015-04-14 Intra-Cellular Therapies, Inc. Method of treating female sexual dysfunction with a PDE1 inhibitor
WO2010065148A1 (en) 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
US9468637B2 (en) 2009-05-13 2016-10-18 Intra-Cellular Therapies, Inc. Organic compounds
US9763948B2 (en) 2010-05-31 2017-09-19 Intra-Cellular Therapies, Inc. PDE1 inhibitory compounds and methods
TW201206937A (en) 2010-05-31 2012-02-16 Intra Cellular Therapies Inc Organic compounds
JP6222776B2 (ja) * 2011-04-21 2017-11-01 オリゲニス ゲーエムベーハーＯｒｉｇｅｎｉｓ Ｇｍｂｈ キナ−ゼ・インヒビタ−として有用なピラゾロ［４，３−ｄ］ピリミジン
WO2014060112A1 (en) 2012-10-19 2014-04-24 Origenis Gmbh Pyrazolo[4,3-d]pyrimidines as kinase inhibitors
EP2956141A4 (en) 2013-02-17 2016-10-26 Intra Cellular Therapies Inc NEW USES
ES2836129T3 (es) 2013-03-15 2021-06-24 Intra Cellular Therapies Inc Compuestos orgánicos
US9545406B2 (en) 2013-03-15 2017-01-17 Intra-Cellular Therapies, Inc. Method of treating a CNS injury with a PDE1 inhibitor
US9884872B2 (en) 2014-06-20 2018-02-06 Intra-Cellular Therapies, Inc. Organic compounds
US10285992B2 (en) 2014-08-07 2019-05-14 Intra-Cellular Therapies, Inc. Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
TWI686394B (zh) 2014-08-07 2020-03-01 美商內胞醫療公司 有機化合物
BR112017005533B1 (pt) 2014-09-17 2023-10-10 Intra-Cellular Therapies, Inc Compostos inibidores de fosfodiesterase 1 (pde1), composição farmacêutica que compreende os ditos compostos e usos dos mesmos no tratamento de uma doença, distúrbio, e/ou lesão do snc e no tratamento e/ou na profilaxia de uma doença, distúrbio e/ou lesão do snp
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
ES2906107T3 (es) 2016-09-12 2022-04-13 Intra Cellular Therapies Inc Usos novedosos
JP7401442B2 (ja) 2018-01-31 2023-12-19 イントラ－セルラー・セラピーズ・インコーポレイテッド 新規使用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH422807A (de) * 1963-08-16 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung von Imidazo- und Pyrimidochinazolinen
US3313815A (en) * 1964-05-04 1967-04-11 Sterling Drug Inc 8-chloropyrazolo-[1, 5-c]quinazoline derivatives and methods of preparing same
US3309369A (en) * 1966-04-11 1967-03-14 Wander Ag Dr A Imidazo- and pyrimido-quinazolines
US3594379A (en) * 1968-09-16 1971-07-20 Sandoz Ag 2,3-dihydroimidazo(1,2-c)quinazolines
DE2058501A1 (de) * 1970-11-27 1972-05-31 Bayer Ag Verfahren zur Herstellung von neuen N-verbrueckten bicyclischen Heteroaromaten
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives
US3984556A (en) * 1973-01-19 1976-10-05 Sandoz, Inc. Alkyl-substituted-tricyclic quinazolinones for lowering blood pressure
JPS516993A (en) * 1974-07-05 1976-01-20 Dainippon Pharmaceutical Co Adeninjudotaino seiho
JPS5398997A (en) * 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation
US4247553A (en) * 1977-10-31 1981-01-27 The Upjohn Company Methods of treating psychosis
US4206123A (en) * 1977-10-31 1980-06-03 Mccall John M Isothiochroman
US4250181A (en) * 1977-10-31 1981-02-10 The Upjohn Company Methods of treating psychosis
US4192803A (en) * 1978-09-15 1980-03-11 American Cyanamid Company 5H-Pyrrolo[2,1-c][1,4]benzodiazepine derivatives
EP0012208B1 (en) * 1978-11-01 1983-01-26 The Wellcome Foundation Limited 9-(3-(3,5-cis-dimethylpiperazino)propyl)-carbazole, its preparation and pharmaceutical compositions containing it
CH643263A5 (de) * 1979-05-11 1984-05-30 Sandoz Ag Benzodiazepine, ihre herstellung und verwendung.
HU178523B (en) * 1979-05-18 1982-05-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing new pyrazolo-quinazoline derivatives
US4230707A (en) * 1979-08-27 1980-10-28 Warner-Lambert Company Oxo-pyrido[1,2-a]thienopyrimidine compounds and methods for their production
US4358456A (en) * 1980-05-03 1982-11-09 John Wyeth & Brother Limited Antipsychotic piperidinomethyl-indole derivatives
US4396770A (en) * 1982-04-09 1983-08-02 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
US4415581A (en) * 1982-04-09 1983-11-15 Hoechst-Roussel Pharmaceuticals Inc. 1-[3-6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-hydroxy-4-phenylpiperidines to treat psychoses
US4409230A (en) * 1982-04-09 1983-10-11 Hoechst-Roussel Pharmaceuticals Inc. Pharmaceutical compositions and methods employing 8-[3-(6-fluoro-1,2-benzisoxazol-3-yl)propyl]-1-phenyl-1,3,8-triazaspiro-[4.]decan-4-one and derivatives thereof
US4374245A (en) * 1982-04-09 1983-02-15 Hoechst-Roussel Pharmaceuticals Inc. 8-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
US4390544A (en) * 1982-04-09 1983-06-28 Hoechst-Roussel Pharmaceuticals Inc. {1-[3-(6-Fluoro-1,2-benzisoxazol-3-yl)propyl]-4-(2-oxo-1-benzimidazolinyl}p
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol

Also Published As

Publication number Publication date
EP0095289A2 (en) 1983-11-30
EP0095289B1 (en) 1986-12-30
NZ204321A (en) 1986-06-11
ES8506004A1 (es) 1985-06-16
DK227183A (da) 1983-11-25
ATE24510T1 (de) 1987-01-15
NO831792L (no) 1983-11-25
JPS58210087A (ja) 1983-12-07
ES529371A0 (es) 1985-07-01
IL68360A0 (en) 1986-10-31
AU1342783A (en) 1983-12-01
US4469868A (en) 1984-09-04
FI74012C (fi) 1987-12-10
NO160444B (no) 1989-01-09
DK161968C (da) 1992-02-03
CA1210393A (en) 1986-08-26
FI831742A0 (fi) 1983-05-18
IL68360A (en) 1986-10-31
PT76745B (en) 1986-04-21
AU553708B2 (en) 1986-07-24
HU187913B (en) 1986-03-28
PH18454A (en) 1985-07-18
DE3368635D1 (en) 1987-02-05
ES8506315A1 (es) 1985-07-01
DK227183D0 (da) 1983-05-20
FI74012B (fi) 1987-08-31
ES522617A0 (es) 1984-09-01
FI831742L (fi) 1983-11-25
IE830822L (en) 1983-11-24
ZA832637B (en) 1984-01-25
EP0095289A3 (en) 1984-09-05
KR870000931B1 (ko) 1987-05-11
ES529372A0 (es) 1985-06-16
HK102989A (en) 1990-01-05
NO160444C (no) 1989-04-19
JPH0320395B2 (es) 1991-03-19
ES529373A0 (es) 1985-06-16
IE55111B1 (en) 1990-06-06
ES8506019A1 (es) 1985-06-16
ES8407051A1 (es) 1984-09-01
GR79262B (es) 1984-10-22
AR240941A1 (es) 1991-03-27
PT76745A (en) 1983-06-01
DK161968B (da) 1991-09-02
KR840004756A (ko) 1984-10-24

Similar Documents

Publication Publication Date Title
AR240941A2 (es) Procedimiento para preparar compuestos de pirazolopirimidinas
AR245700A1 (es) Nuevos derivados de la 2-anilino-pirimidina como agentes antiparasitarios.
ES2125377T3 (es) Azaheterociclicos triciclicos n-acilatados utiles como antagonistas de vasopresina.
HU895815D0 (en) Insecticide compositions containing heterocyclic compounds and process for the preparation of such compounds
AR247565A1 (es) Metodo de preparacion de compuestos de piperidina terapeuticamente activos
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
ES8308327A1 (es) Un procedimiento para la preparacion de nuevos derivados biciclicos de piridin-5-ona.
EP0103833A3 (en) Diazabicyclo(3.3.1)nonanes
AR241474A1 (es) Preparacion de derivados de acido 3-aciltriciclo ¡5.2.1.0(2.6)¿-3-azadecan-4-carboxilico utiles como inhibidores de la enzima convertidora en angiotensina.
AR247402A1 (es) Un procedimiento para preparar antibioticos macrolidos c-20 aminosustituidos
ES2140381T3 (es) Nuevas 4h-pirido-(1,2-a)pirimidin-4-onas disustituidas en 2,9.
GB1111988A (en) 2',3'-dideoxyriboside-2',3'-olefins
AR246972A1 (es) Un procedimiento para producir compuestos de benzodiazepina, y compuestos intermediarios utiles en dicho procedimiento.
ES2056811T3 (es) Derivados de cinolina, procedimiento para su preparacion y composiciones herbicidas que los contienen.
ES8501607A1 (es) Procedimiento para la obtencion de heterociclos nitrogenosos de 5 miembros
PT82071B (pt) Processo para a preparacao de derivados de homocisteina tiolactona
ES476837A1 (es) Procedimientos de preparar derivados pirimidinicos condensa-dos con cabeza de puente de nitrogeno.
YU147179A (en) Process for preparing new imidazo (1,2-a) imidazoles
ES8503000A1 (es) Procedimiento para preparar derivados de 1,7-dihidro-pirrolo (3,4-e)(1,4)diazepin-2-(3h)-ona
JPS5384992A (en) Production of thiazolo(3,2-a)-1,3,5-triazine-4-oxo-2-thione derivative
JPS55154957A (en) 77methyl and 77methyll88lower alkyl b*c cis or transsmorphinann66one compound
JPS51136695A (en) Process for preparing new pyrimido(4,5-d)pyrimidine derivatives
JPS51133487A (en) Process for preparing 3-amino-1-(alpha -carboxy-4-hydroxybenzyl)-2-azetidi nones
ES366822A1 (es) Procedimiento para la preparacion de nuevas pirido (1,2-a)-s-triazinas.
ES8201975A1 (es) Procedimiento para preparar nuevos compuestos de quinolona